Sign in Subscribe
Nanoparticles

Breakthrough in mRNA Delivery: Vitamin E-Based Nanoparticles Show Promise in Cancer Treatment

Strategic Insights

— 1 min read

Scientists at Huazhong University of Science and Technology have made a significant discovery in the field of nanotechnology, developing a novel form of lipid nanoparticles (LNPs) that can efficiently deliver mRNA-based cancer treatments. The research, published in ACS Nano, reveals that the vitamin E-based LNPs can promote cellular uptake, dendritic cells maturation, and antigen presentation, making them a potential game-changer in the fight against cancer.

Key Takeaways:

  • The study demonstrated the effectiveness of vitamin E-based LNPs in delivering mRNA-based cancer treatments, resulting in complete remission in colon cancer by delivering mIL-12.
  • The researchers designed and synthesized a functional vitamin E-based lipid library with distinct head groups, which exhibited immunomodulatory properties, including promotion of cellular uptake, dendritic cells maturation, and antigen presentation.
  • Through iterative optimization of the LNP components and the architecture of ionizable lipids, the researchers established a correlation between the structure of ionizable lipids and their mRNA delivery efficiency.
  • The proposed functional LNPs are anticipated to furnish potential delivery systems for mRNA-based cancer treatments.
  • The study highlighted the importance of ionizable lipids in the effective delivery of mRNA and the potential for tailoring their biological properties to augment therapeutic efficacy.

Statistics:

  • The vitamin E-based LNPs demonstrated complete remission in colon cancer by delivering mIL-12.
  • The researchers found that the proposed functional LNPs had a high mRNA delivery efficiency and immunomodulatory function.
  • The study concluded that the structure of ionizable lipids plays a crucial role in their mRNA delivery efficiency.

Sources:

  • "Iterative Screening of Vitamin E-Based Functional Lipid Nanoparticles for mRNA Delivery" (ACS Nano, 2025)
  • Zhang Fangming et al., Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan 430030, People's Republic of China
  • Additional authors: Kexin Cui, Tianzi Shi, Siyu Zhao, Yixuan Zhou, Xiong Liu, Yong Hu, Zhaoyu Hu, Li Kong, and Zhiping Zhang (ACS Nano, 2025)

Read more